Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-EN Version v10-FR
Language English French
Date Updated 2022-11-04 2022-08-24
Drug Identification Number 00628158 00628158
Brand name APO-AMOXI APO-AMOXI
Common or Proper name AMOXICILLAN AMOXICILLAN
Company Name APOTEX INC APOTEX INC
Ingredients AMOXICILLIN AMOXICILLIN
Strength(s) 250MG 250MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100mL and 150mL 100mL
ATC code J01CA J01CA
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-15 2022-06-15
Estimated end date 2022-12-09 2022-12-23
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments 150mL is available
Health Canada comments